Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Promino Nutritional Sciences Inc. C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Post by KidAtHearton Apr 29, 2024 7:36pm
178 Views
Post# 36013709

LOI with Helios Helium - exciting road ahead?

LOI with Helios Helium - exciting road ahead?

Pursuant to the LOI, Helios will spin out its helium property and sundry assets into a new entity such that Helios's assets will only comprise cash and certain marketable securities. Thereafter, each shareholder of Helios will receive one common share of the company in exchange for each common share of Helios held. Total share consideration is expected to be approximately 36.5 million Promino common shares. The parties and their respective legal and tax advisers will negotiate and execute a definitive agreement setting out the terms and structure for the proposed transaction.

Helios has advanced a bridge loan in the principal amount of $1-million to the company (see news release of the company dated April 19, 2024), which bridge loan is expected to be forgiven on completion of the transaction.

<< Previous
Bullboard Posts
Next >>